09:50 EDT Vaccinex trading halted, volatility trading pause
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VCNX:
- Vaccinex Reports Positive Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease
- Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab
- Vaccinex files to sell 490,509 shares of common stock for holders
- Vaccinex Completes Key Study Phase for Alzheimer’s Drug
- Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease